Holen Sie sich die Stockscreener-App
7.44
0.27%
-0.02
Schlusskurs vom Vortag:
$7.46
Offen:
$7.46
24-Stunden-Volumen:
134.07K
Relative Volume:
0.62
Marktkapitalisierung:
$275.47M
Einnahmen:
$128.45M
Nettoeinkommen (Verlust:
$6.54M
KGV:
148.80
EPS:
0.05
Netto-Cashflow:
$-8.79M
1W Leistung:
-3.25%
1M Leistung:
+7.20%
6M Leistung:
+15.71%
1J Leistung:
+37.78%
1-Tages-Spanne:
$7.39
$7.67
1-Wochen-Bereich:
$7.39
$8.1399
52-Wochen-Spanne:
$3.6793
$8.85
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Firmenname
Lifecore Biomedical Inc
Sektor
Telefon
(952) 368-4300
Adresse
3515 LYMAN BOULEVARD, CHASKA
Vergleichen Sie LFCR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
7.44 | 284.72M | 128.45M | 6.54M | -8.79M | 0.05 |
|
ZTS
Zoetis Inc
|
151.19 | 68.05B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.55 | 46.58B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.65 | 43.71B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.29 | 18.40B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
297.89 | 13.23B | 2.99B | 1.21B | 1.13B | 25.06 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-21 | Eingeleitet | William Blair | Outperform |
| 2024-09-05 | Eingeleitet | Craig Hallum | Buy |
| 2024-08-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2023-03-20 | Herabstufung | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc Aktie (LFCR) Neueste Nachrichten
Lifecore Biomedical Inc. Stock Analysis and ForecastAccelerated earnings growth - jammulinksnews.com
What analysts say about Lifecore Biomedical Inc. stockFree Predictions - jammulinksnews.com
Is Lifecore Biomedical Inc. a good long term investmentUnbelievable profit margins - jammulinksnews.com
Why Lifecore Biomedical Inc. stock attracts strong analyst attentionFree Stock Selection - Newser
What drives Lifecore Biomedical Inc. stock priceSkyrocketing returns - Autocar Professional
Can Lifecore Biomedical Inc. stock recover from recent declineTop Rated Trade Entries - Newser
Will Lifecore Biomedical Inc. stock benefit from interest rate changesWeekly Double Return List - Newser
Lifecore Biomedical (NASDAQ:LFCR) Is Making Moderate Use Of Debt - simplywall.st
Is Lifecore Biomedical Inc. stock a good hedge against inflationSmart High Yield Swing Trades - Newser
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Lifecore Grants 35,913 Shares to New Hires: Complete Inducement Package Details Revealed - Stock Titan
What makes Lifecore Biomedical Inc. stock price move sharplyDaily Price Surge List - Newser
How Lifecore Biomedical Inc. stock performs during market volatilityTrade With Low Risk Exposure - Newser
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Investors to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out - ACCESS Newswire
Lifecore Biomedical Insider Ups Holding During Year - Yahoo
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Connect - ACCESS Newswire
Lifecore Biomedical (LCFY) Poised for Growth Amid Regulatory Momentum and Supply Chain Strength - AInvest
Lifecore Biomedical: Inflecting Financials Over Next 3 Years (NASDAQ:LFCR) - Seeking Alpha
Lifecore Signs 10-Year Manufacturing Deal To Support Novel Ophthalmic Therapy - Nasdaq
Lifecore Biomedical Q3 2025 slides: Revenue dip amid ambitious growth strategy By Investing.com - Investing.com South Africa
Lifecore signs 10-year manufacturing deal with key ophthalmic client By Investing.com - Investing.com Nigeria
Lifecore Biomedical Q3 2025 slides: Revenue dip amid ambitious growth strategy - Investing.com Nigeria
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Connect - ACCESS Newswire
Finanzdaten der Lifecore Biomedical Inc-Aktie (LFCR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.09%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):